122 related articles for article (PubMed ID: 2723025)
1. Persistence of large molecular weight prolactin secretion during pregnancy in women with macroprolactinemia and its presence in fetal cord blood.
Jackson RD; Wortsman J; Malarkey WB
J Clin Endocrinol Metab; 1989 Jun; 68(6):1046-50. PubMed ID: 2723025
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of serum prolactin throughout the menstrual cycle and pregnancy in hyperprolactinemic women with normal ovarian function.
Larrea F; Escorza A; Valero A; Hernandez L; Cravioto MC; Diaz-Sanchez V
J Clin Endocrinol Metab; 1989 May; 68(5):982-7. PubMed ID: 2715295
[TBL] [Abstract][Full Text] [Related]
3. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
Hattori N
J Clin Endocrinol Metab; 1996 Feb; 81(2):586-90. PubMed ID: 8636272
[TBL] [Abstract][Full Text] [Related]
4. Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
J Clin Endocrinol Metab; 2001 Jun; 86(6):2619-24. PubMed ID: 11397862
[TBL] [Abstract][Full Text] [Related]
5. Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women.
Pascoe-Lira D; Duran-Reyes G; Contreras-Hernández I; Manuel-Apolinar L; Blanco-Favela F; Leaños-Miranda A
J Clin Endocrinol Metab; 2001 Feb; 86(2):924-9. PubMed ID: 11158068
[TBL] [Abstract][Full Text] [Related]
6. Long-term assessment of patients with macroprolactinemia.
Malarkey WB; Jackson R; Wortsman J
Fertil Steril; 1988 Sep; 50(3):413-8. PubMed ID: 3137098
[TBL] [Abstract][Full Text] [Related]
7. [Importance of prolactin isoforms on ovary function in hyperprolactinemic women].
Romero C; León J; Jara R; González O
Rev Chil Obstet Ginecol; 1993; 58(6):465-9. PubMed ID: 7991872
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses.
Jackson RD; Wortsman J; Malarkey WB
J Clin Endocrinol Metab; 1985 Aug; 61(2):258-64. PubMed ID: 4008606
[TBL] [Abstract][Full Text] [Related]
9. On the nature of serum prolactin in two patients with macroprolactinemia.
Carlson HE; Markoff E; Lee DW
Fertil Steril; 1992 Jul; 58(1):78-87. PubMed ID: 1624027
[TBL] [Abstract][Full Text] [Related]
10. Variations in the molecular forms of prolactin during the menstrual cycle, pregnancy and lactation.
Fonseca ME; Ochoa R; Morán C; Zárate A
J Endocrinol Invest; 1991 Dec; 14(11):907-12. PubMed ID: 1806609
[TBL] [Abstract][Full Text] [Related]
11. Familial occurrence of big-big prolactin as the predominant immunoreactive human prolactin species in blood.
Larrea F; Escorza A; Granados J; Valencia X; Valero A; Cravioto MC; Pérez-Palacios G
Fertil Steril; 1987 Jun; 47(6):956-63. PubMed ID: 3595901
[TBL] [Abstract][Full Text] [Related]
12. Macroprolactinemia revisited: a study on 106 patients.
Vallette-Kasic S; Morange-Ramos I; Selim A; Gunz G; Morange S; Enjalbert A; Martin PM; Jaquet P; Brue T
J Clin Endocrinol Metab; 2002 Feb; 87(2):581-8. PubMed ID: 11836289
[TBL] [Abstract][Full Text] [Related]
13. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.
Cavaco B; Prazeres S; Santos MA; Sobrinho LG; Leite V
J Endocrinol Invest; 1999 Mar; 22(3):203-8. PubMed ID: 10219888
[TBL] [Abstract][Full Text] [Related]
14. Characterization of big, big prolactin in patients with hyperprolactinaemia.
Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
[TBL] [Abstract][Full Text] [Related]
15. Macroprolactinemia: diagnostic, clinical, and pathogenic significance.
Shimatsu A; Hattori N
Clin Dev Immunol; 2012; 2012():167132. PubMed ID: 23304187
[TBL] [Abstract][Full Text] [Related]
16. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome.
Leaños-Miranda A; Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Parra A; Ramírez-Peredo J
Lupus; 2007; 16(5):342-9. PubMed ID: 17576736
[TBL] [Abstract][Full Text] [Related]
17. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
Lu CC; Hsieh CJ
Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
[TBL] [Abstract][Full Text] [Related]
18. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
[TBL] [Abstract][Full Text] [Related]
19. Zinc does not acutely suppress prolactin in normal or hyperprolactinemic women.
Koppelman MC; Greenwood V; Sohn J; Deuster P
J Clin Endocrinol Metab; 1989 Jan; 68(1):215-8. PubMed ID: 2491863
[TBL] [Abstract][Full Text] [Related]
20. Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
Melis GB; Gambacciani M; Paoletti AM; Beneventi F; Mais V; Baroldi P; Fioretti P
J Clin Endocrinol Metab; 1987 Sep; 65(3):541-5. PubMed ID: 3624413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
